Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
AVORO CAPITAL ADVISORS LLC | 02-14-2024 | 12-31-2023 | 42 | 7,239,756,496 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
HORIZON THERAPEUTICS PLC | Common | Liquidated | $0 | 0 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |
APELLIS PHARMACEUTICALS INC | Common | 2 | $665,111,104 | 11,111,111 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |
UNITED THERAPEUTICS CORP | Common | 3 | $628,640,882 | 2,858,888 | 0.01 | 0.01 | 6,388 | 0.22 | 12-31-2023 |
ASCENDIS PHARMA | Sponsored ADR | 4 | $473,012,152 | 3,755,555 | 0.01 | 0.01 | 85,555 | 2.33 | 12-31-2023 |